BETA
Logo
COVID-19
coronavirus
Ask
HomeInsightsTopicsResources
Back

What is Remdesivir?

Remdesivir (RDV) is a drug slated to combat COVID-19 in severely ill patients and reduce recovery time has been approved for use within Australia hospitals.

However, the drug does not significantly cut the risk of dying from the virus.

COVID-19 drug remdesivir was given provisional approval in Australia on Friday, for use in adults and adolescents with severe virus symptoms.

Preliminary data from a major US government-sponsored clinical trial released in April suggests remdesivir shortened the time to recovery by 31 per cent.

Remdesivir was originally developed by US biotech company Gilead to treat Ebola, but it did not work on that virus. It has not been approved to treat any other condition.

The Therapeutic Goods Administration (TGA) said remdesivir had the potential to reduce the strain on the healthcare system by "reducing recovery times" and freeing up hospital beds.

Source:theage.com.au...

Did you find this helpful?

or
Share on TwitterShare on FacebookShare on LinkedIn

You might also want to ask...

Is there a vaccine or treatment for COVID-19?
EndCoronavirus.org
We educate in order to end the outbreak of Coronavirus COVID-19.
Learn more
Have a good question and answer? Suggest quality content
Logo
Get quick answers around topics you care about

Terms of UsePrivacy PolicyDisclaimer
© 2020 Ask About
© 2020 Ask About